Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma

The progression of non-alcoholic fatty liver disease (NAFLD), the most common liver disease, leads to non-alcoholic steatohepatitis and hepatocellular carcinoma. Despite the increasing incidence and prevalence of NAFLD, its therapeutic and preventive strategies to lower the disease burden is limited...

Full description

Bibliographic Details
Main Authors: Seogsong Jeong, Woo-Young Shin, Yun Hwan Oh
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Endocrinology
Subjects:
non-alcoholic fatty liver disease
immune system
immunity
liver cancer
chronic liver disease
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1150360/full

Similar Items

Similar Items